1 |
von Mücke-Heim IA, Deussing JM. The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside. Neuropharmacology 2023;224:109366. [PMID: 36470368 DOI: 10.1016/j.neuropharm.2022.109366] [Reference Citation Analysis]
|
2 |
Sæther LS, Ueland T, Haatveit B, Maglanoc LA, Szabo A, Djurovic S, Aukrust P, Roelfs D, Mohn C, Ormerod MBEG, Lagerberg TV, Steen NE, Melle I, Andreassen OA, Ueland T. Inflammation and cognition in severe mental illness: patterns of covariation and subgroups. Mol Psychiatry 2022. [PMID: 36577840 DOI: 10.1038/s41380-022-01924-w] [Reference Citation Analysis]
|
3 |
Wang Y, Meng W, Liu Z, An Q, Hu X. Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1046692] [Reference Citation Analysis]
|
4 |
Sæther LS, Ueland T, Haatveit B, Maglanoc LA, Szabo A, Djurovic S, Aukrust P, Roelfs D, Mohn C, Greenwood Ormerod MBE, Lagerberg TV, Steen NE, Melle I, Andreassen OA, Ueland T. Inflammation and cognition in severe mental illness: Patterns of covariation and subgroups.. [DOI: 10.1101/2022.08.25.22279209] [Reference Citation Analysis]
|
5 |
Slaney C, Sallis HM, Jones HJ, Dardani C, Tilling K, Munafò MR, Smith GD, Mahedy L, Khandaker GM, CHARGE Inflammation Working Group. Association between inflammation and cognition: triangulation of evidence using a population-based cohort and Mendelian randomization analyses.. [DOI: 10.1101/2022.08.15.22278773] [Reference Citation Analysis]
|
6 |
Griffiths SL, Upthegrove R, Corsi-zuelli F, Deakin B. Rethinking Immunity and Cognition in Clinical High Risk for Psychosis. Current Topics in Behavioral Neurosciences 2022. [DOI: 10.1007/7854_2022_399] [Reference Citation Analysis]
|